These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35687839)

  • 1. Rituximab or rituximab plus chlorambucil for translocation (11;18)-negative gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomized observational study.
    Lévy M; Dupuis J; Charpy C; Martin A; Itti E; Sobhani I; Haioun C; Amiot A
    Leuk Lymphoma; 2022 Nov; 63(11):2597-2603. PubMed ID: 35687839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
    Amiot A; Lévy M; Copie-Bergman C; Dupuis J; Szablewski V; Le Baleur Y; Baia M; Belhadj K; Sobhani I; Leroy K; Haioun C; Delchier JC
    Aliment Pharmacol Ther; 2014 Mar; 39(6):619-28. PubMed ID: 24467480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study.
    Lévy M; Copie-Bergman C; Amiot A; Dupuis J; Le Baleur Y; Belhadj K; Hémery F; Sobhani I; Delfau-Larue MH; Leroy K; Haioun C; Delchier JC
    Leuk Lymphoma; 2013 May; 54(5):940-4. PubMed ID: 22978684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.
    Lévy M; Copie-Bergman C; Molinier-Frenkel V; Riou A; Haioun C; Gaulard P; Delfau-Larue MH; Sobhani I; Leroy K; Delchier JC
    Leuk Lymphoma; 2010 Feb; 51(2):284-90. PubMed ID: 20038225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study.
    Zucca E; Conconi A; Laszlo D; López-Guillermo A; Bouabdallah R; Coiffier B; Sebban C; Jardin F; Vitolo U; Morschhauser F; Pileri SA; Copie-Bergman C; Campo E; Jack A; Floriani I; Johnson P; Martelli M; Cavalli F; Martinelli G; Thieblemont C
    J Clin Oncol; 2013 Feb; 31(5):565-72. PubMed ID: 23295789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
    Zucca E; Conconi A; Martinelli G; Bouabdallah R; Tucci A; Vitolo U; Martelli M; Pettengell R; Salles G; Sebban C; Guillermo AL; Pinotti G; Devizzi L; Morschhauser F; Tilly H; Torri V; Hohaus S; Ferreri AJM; Zachée P; Bosly A; Haioun C; Stelitano C; Bellei M; Ponzoni M; Moreau A; Jack A; Campo E; Mazzucchelli L; Cavalli F; Johnson P; Thieblemont C
    J Clin Oncol; 2017 Jun; 35(17):1905-1912. PubMed ID: 28355112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
    Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
    Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous Rituximab.
    Rotkopf H; Lévy M; Copie-Bergman C; Dupuis J; Verlinde-Carvalho M; Itti E; Gagniere C; Belhadj K; Tannoury J; Le Bras F; Sobhani I; Haioun C; Amiot A
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e32-e38. PubMed ID: 32921592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database.
    Olszewski AJ; Castillo JJ
    Ann Oncol; 2013 May; 24(5):1352-9. PubMed ID: 23348804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.
    Cencini E; Fabbri A; Lauria F; Bocchia M
    Ann Hematol; 2018 May; 97(5):821-829. PubMed ID: 29340761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
    Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
    Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.
    Ueda K; Terui Y; Yokoyama M; Sakajiri S; Nishimura N; Tsuyama N; Takeuchi K; Hatake K
    Leuk Lymphoma; 2013 Sep; 54(9):1928-33. PubMed ID: 23216271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
    Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
    Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
    Troch M; Kiesewetter B; Willenbacher W; Willenbacher E; Zebisch A; Linkesch W; Fridrik M; Müllauer L; Greil R; Raderer M
    Haematologica; 2013 Feb; 98(2):264-8. PubMed ID: 22983582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
    Wöhrer S; Drach J; Hejna M; Scheithauer W; Dirisamer A; Püspök A; Chott A; Raderer M
    Ann Oncol; 2003 Dec; 14(12):1758-61. PubMed ID: 14630681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
    Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
    Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
    Kiesewetter B; Mayerhoefer ME; Lukas J; Zielinski CC; Müllauer L; Raderer M
    Ann Hematol; 2014 Feb; 93(2):249-53. PubMed ID: 23925930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
    Stathis A; Pirosa MC; Orsucci L; Feugier P; Tani M; Ghesquières H; Musuraca G; Rossi FG; Merli F; Guièze R; Gyan E; Gini G; Marino D; Gressin R; Morschhauser F; Cavallo F; Palombi F; Conconi A; Tessoulin B; Tilly H; Zanni M; Cabras MG; Capochiani E; Califano C; Celli M; Pulsoni A; Angrilli F; Occhini U; Casasnovas RO; Cartron G; Devizzi L; Haioun C; Liberati AM; Houot R; Merli M; Pietrantuono G; Re F; Spina M; Landi F; Cavalli F; Bertoni F; Rossi D; Ielmini N; Borgo E; Luminari S; Zucca E; Thieblemont C
    Haematologica; 2024 Aug; 109(8):2564-2573. PubMed ID: 38385243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.
    Troch M; Woehrer S; Streubel B; Weissel M; Hoffmann M; Müllauer L; Chott A; Raderer M
    Ann Oncol; 2008 Jul; 19(7):1336-1339. PubMed ID: 18334510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.